Surgery Partners, Inc. financial data

Symbol
SGRY on Nasdaq
Location
310 Seven Springs Way, Suite 500, Brentwood, TN
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 7, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 179 % +1.38%
Quick Ratio 14.4 % -1.43%
Return On Equity -5.37 % -1247%
Return On Assets -2.25 % -1171%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 128M shares +0.41%
Common Stock, Shares, Outstanding 127M shares +0.41%
Entity Public Float 2.6B USD -44.7%
Weighted Average Number of Shares Outstanding, Basic 126M shares +0.41%
Weighted Average Number of Shares Outstanding, Diluted 126M shares +0.41%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 139M USD +14.7%
Operating Income (Loss) 349M USD +6.34%
Income Tax Expense (Benefit) 135M USD +1913%
Net Income (Loss) Attributable to Parent -168M USD -1313%
Earnings Per Share, Basic -1.33 USD/shares -1378%
Earnings Per Share, Diluted -1.33 USD/shares -1378%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 270M USD +37.6%
Accounts Receivable, after Allowance for Credit Loss, Current 579M USD +16.7%
Inventory, Net 88.4M USD +17.6%
Other Assets, Current 146M USD +51.3%
Assets, Current 1.12B USD +25.1%
Deferred Income Tax Assets, Net 0 USD -100%
Operating Lease, Right-of-Use Asset 296M USD +15.8%
Intangible Assets, Net (Excluding Goodwill) 45.7M USD -16.6%
Goodwill 5.07B USD +17.2%
Other Assets, Noncurrent 57.5M USD -44.3%
Assets 7.89B USD +14.7%
Accounts Payable, Current 209M USD +21.5%
Employee-related Liabilities, Current 60.4M USD -18.2%
Liabilities, Current 624M USD +19.4%
Long-term Debt and Lease Obligation 3.27B USD +21%
Deferred Income Tax Liabilities, Net 39.2M USD
Operating Lease, Liability, Noncurrent 292M USD +17.4%
Other Liabilities, Noncurrent 30.2M USD -26.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax 4.8M USD -91.7%
Retained Earnings (Accumulated Deficit) -737M USD -29.5%
Stockholders' Equity Attributable to Parent 1.79B USD -9.94%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 3.2B USD +5.34%
Liabilities and Equity 7.89B USD +14.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 40.7M USD -45.4%
Net Cash Provided by (Used in) Financing Activities 31.7M USD
Net Cash Provided by (Used in) Investing Activities -83.1M USD -17.5%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 127M shares +0.41%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -10.7M USD +71.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 270M USD +37.6%
Deferred Tax Assets, Valuation Allowance 285M USD +89.7%
Deferred Tax Assets, Gross 404M USD +5.65%
Operating Lease, Liability 333M USD +16.3%
Payments to Acquire Property, Plant, and Equipment 21M USD -13.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -221M USD -622%
Lessee, Operating Lease, Liability, to be Paid 485M USD +18.5%
Operating Lease, Liability, Current 41M USD +9.04%
Lessee, Operating Lease, Liability, to be Paid, Year Two 62.3M USD +14.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 65.2M USD +10.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Deferred Income Tax Expense (Benefit) 2.5M USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 152M USD +23.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 53.9M USD +6.52%
Deferred Tax Assets, Operating Loss Carryforwards 143M USD -0.49%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20.3M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 43.9M USD +3.05%
Operating Lease, Payments 15.6M USD -3.11%
Additional Paid in Capital 2.52B USD +0.93%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 153M USD +29.2%
Deferred Tax Assets, Net of Valuation Allowance 119M USD -48.7%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%